- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05028972
VA 응급실의 청각 장애, 전략 및 결과 (HearVA-ED)
HearVA(I-HearVA) 구현
HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.
연구 개요
상세 설명
HearVA is a randomized controlled trial to explore the utility and outcomes of providing point-of-care access to hearing-impaired Veterans, comparing an offer of personal amplifiers versus control in an environment where the clinical stakes are high. It addresses a knowledge gap about the utility of providing such hearing assistance during clinical encounters. The study measures whether providing personal amplifiers is acceptable to older patients, can improve hearing, enhance understanding of discharge instructions, and improve care transitions at discharge. If such a strategy is beneficial, this simple low-tech approach has great potential for implementation and wide dissemination. HearVA-ED has two phases - the first, which has been completed, established the feasibility and acceptability of research and procedures in the ED environment through a pilot efficacy study and the second phase will be to complete a larger more definitive efficacy study and a detailed implementation study resulting in a strategic approach that can be widely disseminated across all VA emergency departments throughout the United States. This second phase will use a mixed-methods, hybrid effectiveness-implementation design to implement and evaluate the hearing assistance intervention in six VA Emergency Department Sites (in different facilities across the country). Implementation will occur in four stages with variation in the starting sequence at each site: The first group of two VA emergency departments will initiate implementation with an efficacy trial; second group of two sites will initiate implementation with delivery and support of personal amplifiers after screening and randomization by a research assistant (Stage 1); the third group of two sites will initiate implementation with the entire implementation (Stage 2) and the presence of a research assistant to conduct discharge interviews; and all sites will progress from this sequence to Stage 3 - Sustainability - which is the full implementation without research assistant presence.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Joshua Chodosh, MD MSHS
- 전화번호: 48491 (310) 478-3711
- 이메일: Joshua.Chodosh@va.gov
연구 연락처 백업
- 이름: Lin T Tun
- 전화번호: (646) 501-4132
- 이메일: lin.tun@va.gov
연구 장소
-
-
Colorado
-
Aurora, Colorado, 미국, 80045-7211
- 모병
- Rocky Mountain Regional VA Medical Center, Aurora, CO
-
연락하다:
- Lauren Abbate, MD
- 전화번호: 3177 303-399-8020
- 이메일: lauren.abbate@va.gov
-
-
New York
-
New York, New York, 미국, 10010-5011
- 모병
- VA NY Harbor Healthcare System, New York, NY
-
수석 연구원:
- Joshua Chodosh, MD MSHS
-
연락하다:
- Olga Dotsenko
- 전화번호: 3323 (212) 686-7500
- 이메일: olga.dotsenko@va.gov
-
연락하다:
- Andrea M Aquines
- 전화번호: (212) 686-7500
- 이메일: andrea.aquines@va.gov
-
Syracuse, New York, 미국, 13210-2716
- 모집하지 않고 적극적으로
- Syracuse VA Medical Center, Syracuse, NY
-
The Bronx, New York, 미국, 10468
- 모병
- James J. Peters VA Medical Center, Bronx, NY
-
연락하다:
- Ula Hwang, MD
- 전화번호: 3816 718-584-9000
- 이메일: ula.hwang@va.gov
-
-
North Carolina
-
Durham, North Carolina, 미국, 27705-3875
- 모병
- Durham VA Medical Center, Durham, NC
-
연락하다:
- Luna Ragsdale, MD
- 이메일: luna.ragsdale@va.gov
-
-
Texas
-
Dallas, Texas, 미국, 75216-7167
- 모병
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
-
연락하다:
- Rohit Manaktala, MD
- 이메일: Rohit.Manaktala@va.gov
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- English speaking
- Emergency severity index criterion of 3 (medium), 4, or 5 (low acuity)
- Hearing Handicap Inventory-Screen greater than or equal to 10 or positive answer to a single-item screening question
- Capacity to consent to participate in research
Exclusion Criteria:
- Inability to consent to participate in research
- Emergency severity index criterion of 1-2 (high acuity)
- Hearing Handicap Inventory-Screen less than 10 and negative answer to single item screening question
- Inability to speak English
- Using cochlear implants
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Intervention: Personal Amplifier
Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department |
The intervention group will receive personal amplifiers (PockeTalkers) while they receive care in the ED
다른 이름들:
|
|
다른: Control: No Personal Amplifier
Consenting participants will be randomly assigned to the control group while receiving care in the emergency department |
The control group will not receive personal amplifiers while they receive care in the ED |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Emergency department (ED) 3-day Readmissions
기간: 3-5 days after initial ED stay
|
The Investigators will determine whether patients have had an ED revisit within three days through CPRS review as well as a brief follow-up phone call 3-5 days after ED discharge |
3-5 days after initial ED stay
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Emergency department (ED) 30-day Readmissions
기간: 30-35 days after initial ED stay
|
The Investigators will determine whether patients have had an ED revisit within 30 days through CPRS review as well as a brief follow-up phone call 30-35 days after ED discharge |
30-35 days after initial ED stay
|
|
Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During Emergency department (ED) Stay
기간: Duration of ED stay, average of 1 day
|
Participants will self-rate their quality of hearing, understanding, and communication using a six item questionnaire. Scored on a 10-point Likert scale (1 = do not agree at all; 10 = completely agree) the questions will be: When I talked to the doctors and nurses today ... (1) their voices were very clear; (2) I was able to hear the sounds that I wanted to hear; (3) noises did not cause a problem for my hearing; and (4) listening did not make me tired. Two additional statements will explicitly capture understanding: (5) I was able to understand what they said; and (6) I was able to understand without making an effort. Higher scores will indicate better communication and understanding with providers. |
Duration of ED stay, average of 1 day
|
|
Patient-Rated Quality of Post-Discharge Care
기간: At time of discharge from ED, average 1 day
|
Patient-rated quality of post-discharge care using a three-item subset of the Care Transition Measure (CTM). The questions are scored on a 1-4 scale (1= strongly disagree; 4 = strongly agree): (1) The ED staff considered my preferences and those of my family or caregiver in deciding what my healthcare needs were for discharge; (2) Leaving the ED, I have a good understanding of the things I am responsible for in managing my health; (3) Leaving the ED, I clearly understand the purpose for each of my medications. Higher scores will indicate better discharge preparation. |
At time of discharge from ED, average 1 day
|
|
Self-Reported Understanding of Discharge Instructions
기간: 3-5 days after initial ED stay
|
Investigators will gauge self-reported understanding of discharge instructions using semi-structured interview data compared to documented discharge data. |
3-5 days after initial ED stay
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Joshua Chodosh, MD MSHS, VA NY Harbor Healthcare System, New York, NY
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- IIR 17-068-1
- HX002421 (기타 보조금/기금 번호: VA HSR&D)
- 5I01HX002421-08 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .